Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: Prospective analysis

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 4, 2015, Pages 479-484

  Abdelaziz, Ashraf Omar ^a   Nabeel, Mohamed Mahmoud ^a   Elbaz, Tamer Mahmoud ^a   Shousha, Hend Ibrahim ^b   Hassan, Eman Medhat ^a   Mahmoud, Sherif Hamdy ^a   Rashed, Noha Ali ^a   Ibrahim, Mostafa Mohamed ^a   Abdelmaksoud, Ahmed Hosni ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Cairo University   (Egypt)

Author keywords

Hepatocellular carcinoma; microwave ablation; survival; transarterial chemoembolization

Indexed keywords

ADULT; ARTICLE; ASCITES; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; ECHOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR VOLUME; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPARATIVE STUDY; FOLLOW UP; LIVER NEOPLASMS; MICROWAVE RADIATION; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; THERAPEUTIC USE; TUMOR RECURRENCE;

ASCITES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN;

EID: 84923995203     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.1003397     Document Type: Article

References (35)

1. Elbaz T, Kassas M, Esmat G. Management of Hepatocellular Carcinoma: Updated Review. J Cancer Ther 2013;4:536-45.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
3. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010;7:448-58.
4. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35: 519-24.
5. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patient with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;14:1734-9.
6. Lo CM, Nqan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;14:1164-7.
7. Zhang L, Yin X, Gan YH, Zhang BH, Zhang JB, Chen Y, et al. Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol 2014;14:11.
8. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Guilk TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005;14: 331-47.
9. Cheng AL, Amarapurkar D, Chao Y, Chen PJ, Geschwind JF, Goh KL, et al. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an international expert panel. Liver Int 2014;34:174-83.
10. Van Ha TG. Transarterial chemoembolization for hepatocellular carcinoma. Semin Intervent Radiol 2009;26:270-5.
11. Abdelaziz A, Elbaz T, Shousha HI, Mahmoud S, Ibrahim M, Abdelmaksoud A, et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an egyptian multidisciplinary clinic experience. Surg Endosc 2014;28:3429-34.
12. Poggi G, Montagna B, DI Cesare P, Riva G, Bernardo G, Mazzucco M, et al. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res 2013;33:1221-7.
13. Brace CL. Dual-slot antennas for microwave tissue heating: parametric design analysis and experimental validation. Med Phys 2011;38:4232-40.
14. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the barcelona-2000 EASL conference. european association for the study of the liver. J Hepatol 2001;35:421-30.
15. Bruix J, Sherman M. American association for the study of liver diseases. management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
16. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-7.
17. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;14:429-42.
18. Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, et al. Liver metastases: neoadjuvant downsizing with trans-arterial chemoembolization before laser-induced thermotherapy. Radiology 2003;14:457-64.
19. Lin SM, Lin DY. Percutaneous local ablation therapy in small hepatocellular carcinoma. Chang Gung Med J 2003; 26:308-14.
20. Qian GJ, Wang N, Shen Q, Sheng YH, Zhao JQ, Kuang M, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies. Eur Radiol 2012;22: 1983-90.
21. Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012;262:43-58.
22. Jiao DC, Zhou Q, Han XW, Wang YF, Wu G, Ren JZ, et al. Microwave ablation treatment of liver cancer with a 2,450-MHz cooled-shaft antenna: pilot study on safety and efficacy. Asian Pac J Cancer Prev 2012;13:737-42.
23. Liu Y, Zheng Y, Li S, Li B, Zhang Y, Yuan Y. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol 2013;68:21-6.
24. Biolato M, Marrone G, Racco S, Di Stasi C, Miele L, Gasbarrini G, et al. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? Eur Rev Med Pharmacol Sci 2010;14:356-62.
25. Paul SB, Gamanagatti S, Sreenivas V, Chandrashekhara SH, Mukund A, Gulati MS, et al. Trans-arterial chemoembolization (TACE) in patients with unresectable Hepatocellular carcinoma: Experience from a tertiary care centre in India. Indian J Radiol Imaging 2011;21:113-20.
26. Wang P, Sheng L, Wang G, Wang H, Huang X, Yan X, et al. Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma. Mol Clin Oncol 2014;2:203-6.
27. Abdelaziz AO, Elbaz TM, Shousha HI, Ibrahim MM, Rahman El-Shazli MA, Abdelmaksoud AH, et al. Survival and prognostic factors for hepatocellular carcinoma: an egyptian multidisciplinary clinic experience. Asian Pac J Cancer Prev 2014;15:3915-20.
28. Zhong JH, Xiang BD, Gong WF, Ke Y,Mo QG, Ma L, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One 2013;8:e68193.
29. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009;249:195-202.
30. Jin YJ, Lee JW, Choi YJ, Chung HJ, Kim YS, Lee KY, et al. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A. J Gastrointest Surg 2014;18:555-61.
31. Liu PH, Lee YH, Hsu CY, Hsia CY, Huang YH, Chiou YY, et al. Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond milan criteria independent of performance status. J Gastrointest Surg 2014;18:1623-31.
32. Gao F, Gu YK, Fan WJ, Zhang L, Huang JH. Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma. World J Gastroenterol 2011;17:3145-50.
33. Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, et al. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol 2007;17:553-63.
34. Zhang L, Hu P, Chen X, Bie P. Transarterial chemoembolization (TACE) plus Sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis. PLoS One 2014;9:e100305.
35. Xu LF, Sun HL, Chen YT, Ni JY, Chen D, Luo JH, et al. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol 2013;28:456-63.